我院骨外科I类切口手术抗菌药物用药分析
Application Analysis of Prophylactic Antimicrobial Agents during Orthopedics Type I Incision during Perioperative Period
摘要: 目的:通过分析我院骨外科I类切口手术预防性使用抗菌药物情况,为我院骨外科病区围手术期预防性使用抗菌药物的合理性提供参考。方法:随机抽取2019年8月至2021年8月我院骨外科I类切口手术病例338例,对病例中使用抗菌药物的品种、给药时机及用药时长等进行回顾性调查分析。结果:我院骨外科I类切口手术围术期抗菌药物2019~2020年、2020~2021年围手术期使用抗菌药物率分别为95.2%、98.8%。2019~2021年间抗菌药物的使用率前三分别是头孢唑林钠、头孢呋辛钠、头孢硫脒。结论:我院骨外科围手术期I类切口使用抗菌药物时总体规范,但仍存在不合理现象,应予以关注并干预,以促进抗菌药物的合理应用。
Abstract:
Objective: To provide a reference for using prophylactic antibiotics during the perioperative period by analyzing the situation of using prophylactic antimicrobial agents during type I incision surgery in the Department of Orthopedics of our hospital. Methods: 338 cases of type I incision surgery in the Department of Orthopedics in our hospital from August 2019 to August 2021 were randomly selected; Retrospectively investigating and analyzing those cases with what antibiotics were used, when began to be used and the duration of used antimicrobial agents. Results: The perioperative rate of antibiotics used in type I incision surgery in the Department of Orthopedics in our hospital from 2019 to 2020 and from 2020 to 2021 were95.2% and 98.8%, respectively. The top three antibiotics used in 2019~2021 were cefazolin sodium, cefuroxime sodium, and cefathiamidine. Conclusion: In those cases, antibiotics were generally reasonably used in type I incision during the perioperative period in the Department of Orthopedics in our hospital, but there were still unreasonable phenomena, which should be noticed and intervened to promote reasonable application of antibiotics.
参考文献
|
[1]
|
国家卫生计生委办公厅, 国家中医药管理局办公室, 解放军总后勤部卫生部药品器材局. 关于印发抗菌药物临床应用指导原则(2015年版)的通知[EB/OL].
http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml, 2015-7-25.
|
|
[2]
|
国家抗微生物治疗指南[M]. 第2版. 北京: 人民卫生出版社, 2017: 1-342.
|
|
[3]
|
中华医学会外科学分会, 中华外科杂志编辑委员会. 围手术期预防应用抗菌药物指南[J]. 中华外科杂志, 2006, 44(23): 1594-1596.
|
|
[4]
|
杨玉琴. 我院I类切口手术围手术期抗菌药物预防使用情况调查及合理性评价[J]. 海峡药学, 2022, 34(1): 189-191.
|
|
[5]
|
马静. 我院骨科围手术期I类切口抗菌药物预防应用分析[J]. 海峡药学, 2019, 31(11): 224-226.
|
|
[6]
|
徐晖, 黄水金, 夏丽珍, 姜洪满. 某院4406例I类切口手术预防用抗菌药物情况分析[J]. 海峡药学, 2022, 34(5): 126-128.
|
|
[7]
|
陈春泉, 陈春草, 廖世达. 普外科I类切口围术期抗菌药物预防应用分析[J]. 基层医学论坛, 2022, 26(7): 127-129. [Google Scholar] [CrossRef]
|
|
[8]
|
杨文芬, 王春胜. 2017~2019年天津市滨海新区汉沽中医医院I类切口围手术期预防用抗菌药物的合理性分析[J].现代药物与临床, 2020, 35(11): 2268-2272.
|
|
[9]
|
李艺敏. 合理用药干预对I类切口手术围手术期预防用抗菌药物的影响[J]. 药品评价, 2019, 16(13): 32-33+40.
|
|
[10]
|
陈秋萍, 钱娜, 缪莉, 王林艳, 邵志焰. 我院I类切口围术期抗菌药物预防性应用情况的研究[J]. 中国处方药, 2022, 20(4): 61-62.
|
|
[11]
|
吴勤研, 杨元素, 吴锐, 岳慧杰. 某院2018年I类切口手术围术期抗菌药物预防使用分析[J]. 海峡药学, 2022, 34(6): 136-139.
|